ACM
KURA icon

ADAR1 Capital Management’s Kura Oncology KURA Stock Holding History

ADAR1 Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Hold
40,000
– – 0.02% 220
2026
Q1 		$325K Hold
40,000
– – 0.02% 233
2025
Q4 		$416K Sell
40,000
-15,000
-27% -$157K 0.03% 197
2025
Q3 		$487K Buy
55,000
+20,700
+60% +$148K 0.05% 138
2025
Q2 		$198K Buy
34,300
+9,300
+37% +$57K 0.03% 155
2025
Q1 		$165K Buy
+25,000
New +$195K 0.03% 152
2024
Q4 		– Sell
-30,000
Closed -$586K – 262
2024
Q3 		$586K Buy
+30,000
New +$608K 0.1% 106

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

ADAR1 Capital Management's KURA Position: Q2 2026 in Review

ADAR1 Capital Management held its Kura Oncology (KURA) position steady in Q2 2026 at 40,000 shares worth $439K. The position accounts for 0.02% of the portfolio, ranked #220.

ADAR1 Capital Management first reported a position in KURA in Q3 2024 and has held it in 7 quarters since. The position peaked at $586K in Q3 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • ADAR1 Capital Management held 40,000 shares of Kura Oncology worth $439K as of Q2 2026.
  • ADAR1 Capital Management left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #220 holding.
  • ADAR1 Capital Management first reported a position in Kura Oncology in Q3 2024 and has held it in 7 quarters since.
  • ADAR1 Capital Management's Kura Oncology position peaked at $586K in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.